Compounds > aluminum sulfate
Page last updated: 2024-08-22

aluminum sulfate and Herpes Genitalis

aluminum sulfate has been researched along with Herpes Genitalis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awasthi, S; Friedman, HM; Hook, LM; Shaw, CE1
Awasthi, S; Bett, AJ; Brooks, B; Cairns, TM; Cohen, GH; Ditto, NT; Espeseth, AS; Friedman, HM; Gindy, ME; Hook, LM; Smith, JS; Swaminathan, G1
Bernstein, DI; Bravo, FJ; Cardin, R; Earwood, J; Fairman, J; Farley, N; McNeal, M1
Kraynyak, KA; Levinson, MS; Morello, CS; Spector, DH1
Bright, H; Chappell, D; Christy, C; Cockle, P; Evans, DM; Eyles, J; Gore, K; Hammond, D; Khodai, T; Lang, S; Loudon, PT; McCluskie, MJ; Townend, T; West, K; Wright, P1
Chen, Z; Kraynyak, KA; Lee, KF; Levinson, MS; Morello, CS; Spector, DH1
Almond, J; Anderson, SF; Baloglu, S; Catalan, J; Delagrave, S; DiNapoli, JM; Hamberger, JF; Hernandez, H; Kleanthous, H; Londoño-Hayes, P; Mundle, ST; Parrington, M; Zhou, C1
Bernstein, D1
Bell, SJ; He, Q; Johnson, SL; Mitchell, AR; Morcol, T; Wagner-Bartak, C1

Reviews

1 review(s) available for aluminum sulfate and Herpes Genitalis

ArticleYear
Glycoprotein D adjuvant herpes simplex virus vaccine.
    Expert review of vaccines, 2005, Volume: 4, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Alum Compounds; Animals; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Herpes Genitalis; Herpes Simplex Virus Vaccines; Humans; Lipid A; Male; Vaccination; Viral Envelope Proteins

2005

Other Studies

8 other study(ies) available for aluminum sulfate and Herpes Genitalis

ArticleYear
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.
    Human vaccines & immunotherapeutics, 2017, 12-02, Volume: 13, Issue:12

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigens, Viral; Disease Models, Animal; Female; Glycoproteins; Guinea Pigs; Herpes Genitalis; Herpesvirus Vaccines; Immunotherapy; Oligodeoxyribonucleotides; Secondary Prevention; Treatment Outcome; Vaccines, Subunit

2017
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
    Vaccine, 2019, 06-27, Volume: 37, Issue:29

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody Formation; Biosensing Techniques; Epitopes; Female; Herpes Genitalis; Herpesvirus Vaccines; Immune Evasion; Immunogenicity, Vaccine; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Viral Envelope Proteins; Virus Internalization

2019
The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.
    Vaccine, 2010, May-07, Volume: 28, Issue:21

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Female; Guinea Pigs; Herpes Genitalis; Herpes Simplex Virus Vaccines; Herpesvirus 2, Human; Liposomes; Viral Envelope Proteins; Virus Shedding

2010
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.
    Journal of virology, 2011, Volume: 85, Issue:7

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; DNA, Viral; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Immunization, Secondary; Lipid A; Secondary Prevention; Vaccination; Vaccines, DNA; Vaccines, Inactivated

2011
Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.
    Clinical and vaccine immunology : CVI, 2011, Volume: 18, Issue:10

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Disease Models, Animal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Interferon-gamma; Lipid A; Mice; Oligodeoxyribonucleotides; Severity of Illness Index; T-Lymphocytes; Viral Envelope Proteins

2011
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.
    Vaccine, 2012, Oct-12, Volume: 30, Issue:46

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Viral; Disease Models, Animal; Female; Ganglia, Spinal; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Lipid A; Mice; Mice, Inbred BALB C; Survival Analysis; Vaccination; Vaccines, DNA; Vagina; Virus Shedding

2012
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Disease Models, Animal; Female; Ganglia, Spinal; Herpes Genitalis; Herpes Simplex Virus Vaccines; Herpesvirus 2, Human; Humans; Injections, Intramuscular; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Vaccines, Attenuated; Vaccines, Subunit; Vagina; Viral Envelope Proteins

2012
Calcium phosphate nanoparticle adjuvant.
    Clinical and diagnostic laboratory immunology, 2000, Volume: 7, Issue:6

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Calcium Phosphates; Epstein-Barr Virus Infections; Female; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus 4, Human; Humans; Immunoglobulin E; Immunoglobulin G; Inflammation; Male; Mice; Mice, Inbred BALB C; Neutralization Tests; Viral Vaccines

2000